The role of corticotropin-releasing hormone (CRH) family in tumors

Neoplasma. 2021 Sep 17:210219N226. doi: 10.4149/neo_2021_210219N226. Online ahead of print.ABSTRACTThe corticotropin-releasing hormone (CRH) family is widely distributed among the central nervous system and peripheral tissues, such as the digestive, cardiovascular, immune, reproductive, endocrine systems. The CRH family members are widely involved in the regulation of human cell biological processes, immune response, and regulation of inflammatory processes that can affect the occurrence and development of tumors. At present, CRH family members and their receptors can be detected in many tumor tissues, and some people think that members of the CRH family may be potential tumor treatment targets as they can affect cellular processes, such as proliferation, migration, invasion, and apoptosis. However currently, there is no systematic introduction to the relationship between the CRH family and various tumors. This review introduces the molecular regulation of the CRH family in tumor formation and seeks further targeted therapy.PMID:34533028 | DOI:10.4149/neo_2021_210219N226
Source: Neoplasma - Category: Cancer & Oncology Authors: Source Type: research